Maxigen Biotech Inc. reported consolidated revenues results for the month and year-to-date ended June 2022. For the month, the company reported revenue of approximately TWD 62.372 million, an increase of 29.83% over the same period in 2021.

For the year-to-date, the company reported revenue totaled TWD 277.516 million, an increase of 19.58% compared to the TWD 232.083 million for the same period in 2021.